Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -469 | -234 | -8 | 11 | -1,311 |
| Accounts receivable | -23 | N/A | N/A | N/A | N/A |
| Other Working Capital | -32 | -17 | 57 | 34 | 931 |
| Other Operating Activity | 23 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-501 | $-251 | $49 | $45 | $-380 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 43,600 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -524 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $43,076 |
| Beginning Cash Position | 48,142 | 48,142 | 48,142 | 48,142 | 5,446 |
| End Cash Position | 47,641 | 47,891 | 48,191 | 48,187 | 48,142 |
| Net Cash Flow | $-501 | $-251 | $49 | $45 | $42,696 |
| Free Cash Flow | |||||
| Operating Cash Flow | -501 | -251 | 49 | 45 | -380 |
| Free Cash Flow | -501 | -251 | 49 | 45 | -380 |